Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
Executive Summary
Cook Medical’s Zilver PTX stent and Second Sight Medical Products’ Argus II retinal prosthesis system will enjoy new-technology add-on payments in 2014 under CMS’ hospital inpatient prospective payment system final rule.
You may also be interested in...
Eye Disorders Are Focus Of Novel Neurostimulation Technologies
Neurostimulation technology is migrating into the ophthalmology field, and the implications could be significant for the millions of patients worldwide with degenerative eye diseases, including retinitis pigmentosa and age-related macular degeneration, as well as those with moderate-to-severe dry eye disease. Companies active in this space include Second Sight Medical Products, Retina Implant AG, Pixium Vision, Nano Retina, and many others.
Cook Recalls Zilver Drug-Eluting Stent Due To Catheter Separation Issue
Cook Medical has stopped shipments and initiated a global recall of its Zilver PTX drug-eluting stent due to reports of the device’s delivery system separating at the tip of the inner catheter.